Moderna Inc. (MRNA)
27.43
0.21 (0.77%)
At close: Apr 28, 2025, 11:19 AM
Moderna Revenue Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Arrangement Revenue | n/a | 7M | 6M | 3M | n/a | 19M | 13M | 2M | 290M | 100M | 35M | 15M | 10M | 23M | 18M | 10M | 78.04M | 145.69M | 37.91M | 3.19M | 10.05M | 9.61M | 9.84M | 13.3M |
| Collaboration Arrangement Revenue Growth | -100.00% | +16.67% | +100.00% | n/a | -100.00% | +46.15% | +550.00% | -99.31% | +190.00% | +185.71% | +133.33% | +50.00% | -56.52% | +27.78% | +80.00% | -87.19% | -46.44% | +284.33% | +1089.49% | -68.28% | +4.49% | -2.32% | -26.01% | n/a |
| Grant Revenue | 9M | 8M | 20M | n/a | n/a | 44M | 28M | 24M | n/a | 144M | 183M | 126M | 262M | 140M | 139M | 194M | 341.37M | 12.22M | 28.44M | 3.93M | 3.5M | 3.71M | 3.05M | 1.91M |
| Grant Revenue Growth | +12.50% | -60.00% | n/a | n/a | -100.00% | +57.14% | +16.67% | n/a | -100.00% | -21.31% | +45.24% | -51.91% | +87.14% | +0.72% | -28.35% | -43.17% | +2694.45% | -57.05% | +623.35% | +12.28% | -5.56% | +21.45% | +59.84% | n/a |
| Product Sales Revenue | 386M | 2.96B | 645M | 522M | 2.96B | 2.42B | 1B | 1.83B | 4.08B | 3.9B | 4.53B | 5.92B | n/a | 9.62B | 6.14B | 4.47B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Product Sales Revenue Growth | -86.98% | +359.53% | +23.56% | -82.34% | +22.11% | +142.00% | -45.30% | -55.19% | +4.59% | -13.93% | -23.53% | n/a | -100.00% | +56.47% | +37.56% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Europe Revenue | 598M | 1.35B | 6.82B | 6.85B | 38.87M |
| Europe Revenue Growth | -55.87% | -80.12% | -0.45% | +17514.37% | n/a |
| United States Revenue | 1.78B | 1.9B | 7.3B | 5.45B | 764.53M |
| United States Revenue Growth | -5.80% | -74.03% | +33.96% | +612.60% | n/a |
| Rest Of The World Revenue | 810M | 3.6B | 5.15B | 6.18B | n/a |
| Rest Of The World Revenue Growth | -77.49% | -30.14% | -16.63% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 351M | 281M | 268M | 274M | 470M | 442M | 332M | 305M | 375M | 278M | 211M | 268M | 201M | 168M | 121M | 77M | 78.99M | 48.54M | 36.62M | 24.11M | 25.86M | 28.19M | 28.52M | 27.28M | 38.02M | 18.52M | 21.39M | 16.32M | 15.9M | 16.73M | 16.04M | 16.04M |
| Selling, General, and Administrative Revenue Growth | +24.91% | +4.85% | -2.19% | -41.70% | +6.33% | +33.13% | +8.85% | -18.67% | +34.89% | +31.75% | -21.27% | +33.33% | +19.64% | +38.84% | +57.14% | -2.52% | +62.73% | +32.55% | +51.87% | -6.74% | -8.27% | -1.17% | +4.54% | -28.25% | +105.25% | -13.38% | +31.07% | +2.59% | -4.93% | +4.28% | 0.00% | n/a |
| Research and Development Revenue | 1.12B | 1.14B | 1.18B | 1.03B | 1.41B | 1.16B | 1.15B | 1.13B | 1.21B | 820M | 710M | 554M | 648M | 521M | 421M | 401M | 758.86M | 344.49M | 151.86M | 115.14M | 118.75M | 119.72M | 128.5M | 130.57M | 150.43M | 109.05M | 104.48M | 90.12M | 117.83M | 93.61M | 99.51M | 99.51M |
| Research and Development Revenue Growth | -1.32% | -3.64% | +14.90% | -26.96% | +21.21% | +1.05% | +1.50% | -6.61% | +47.68% | +15.49% | +28.16% | -14.51% | +24.38% | +23.75% | +4.99% | -47.16% | +120.29% | +126.85% | +31.89% | -3.05% | -0.80% | -6.83% | -1.59% | -13.20% | +37.94% | +4.38% | +15.93% | -23.51% | +25.87% | -5.93% | 0.00% | n/a |